TIME Is a Great Healer—Targeting Myeloid Cells in the Tumor Immune Microenvironment to Improve Triple-Negative Breast Cancer Outcomes
The word myeloid is derived from the Greek word <i>muelós</i> which means “marrow”. Therefore, myeloid cells are described as cells that arise in the bone marrow. They can be distinguished from lymphoid cells based on their different differentiation trajectories—Lymphoid cells (B and T c...
Main Authors: | Swarnima Singh, Xiang H. F. Zhang, Jeffrey M. Rosen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/1/11 |
Similar Items
-
Design, Synthesis, and Evaluation of Novel Cryptotanshinone Derivatives for Activity against Triple-Negative Breast Cancer
by: Siyu Liu, et al.
Published: (2024-06-01) -
Role of Tumor-Associated Myeloid Cells in Breast Cancer
by: Yoon Jin Cha, et al.
Published: (2020-07-01) -
RAC‐ing up tumour stemness: Disabled homolog 2 interacting protein and triple‐negative breast cancer
by: Joe R Delaney
Published: (2023-02-01) -
Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
by: Srijan Basu, et al.
Published: (2023-11-01) -
Beyond Triple-Negative: High Prevalence of Quadruple-Negative Breast Cancer in African Americans
by: Oluwadamilola Oladeru, et al.
Published: (2024-07-01)